These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 21459945)

  • 1. Candidate genes in patients with autoinflammatory syndrome resembling tumor necrosis factor receptor-associated periodic syndrome without mutations in the TNFRSF1A gene.
    Borghini S; Fiore M; Di Duca M; Caroli F; Finetti M; Santamaria G; Ferlito F; Bua F; Picco P; Obici L; Martini A; Gattorno M; Ceccherini I
    J Rheumatol; 2011 Jul; 38(7):1378-84. PubMed ID: 21459945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The novel S59P mutation in the TNFRSF1A gene identified in an adult onset TNF receptor associated periodic syndrome (TRAPS) constitutively activates NF-κB pathway.
    Greco E; Aita A; Galozzi P; Gava A; Sfriso P; Negm OH; Tighe P; Caso F; Navaglia F; Dazzo E; De Bortoli M; Rampazzo A; Obici L; Donadei S; Merlini G; Plebani M; Todd I; Basso D; Punzi L
    Arthritis Res Ther; 2015 Apr; 17(1):93. PubMed ID: 25888769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pro-inflammatory signalome is constitutively activated by C33Y mutant TNF receptor 1 in TNF receptor-associated periodic syndrome (TRAPS).
    Negm OH; Mannsperger HA; McDermott EM; Drewe E; Powell RJ; Todd I; Fairclough LC; Tighe PJ
    Eur J Immunol; 2014 Jul; 44(7):2096-110. PubMed ID: 24668260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autophagy contributes to inflammation in patients with TNFR-associated periodic syndrome (TRAPS).
    Bachetti T; Chiesa S; Castagnola P; Bani D; Di Zanni E; Omenetti A; D'Osualdo A; Fraldi A; Ballabio A; Ravazzolo R; Martini A; Gattorno M; Ceccherini I
    Ann Rheum Dis; 2013 Jun; 72(6):1044-52. PubMed ID: 23117241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced tumor necrosis factor signaling in primary human fibroblasts containing a tumor necrosis factor receptor superfamily 1A mutant.
    Siebert S; Amos N; Fielding CA; Wang EC; Aksentijevich I; Williams BD; Brennan P
    Arthritis Rheum; 2005 Apr; 52(4):1287-92. PubMed ID: 15818692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel mutation (T61I) in the gene encoding tumour necrosis factor receptor superfamily 1A (TNFRSF1A) in a Japanese patient with tumour necrosis factor receptor-associated periodic syndrome (TRAPS) associated with systemic lupus erythematosus.
    Ida H; Kawasaki E; Miyashita T; Tanaka F; Kamachi M; Izumi Y; Huang M; Tamai M; Origuchi T; Kawakami A; Migita K; Motomura M; Yoshimura T; Eguchi K
    Rheumatology (Oxford); 2004 Oct; 43(10):1292-9. PubMed ID: 15280569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential impact of high and low penetrance TNFRSF1A gene mutations on conventional and regulatory CD4+ T cell functions in TNFR1-associated periodic syndrome.
    Pucino V; Lucherini OM; Perna F; Obici L; Merlini G; Cattalini M; La Torre F; Maggio MC; Lepore MT; Magnotti F; Galgani M; Galeazzi M; Marone G; De Rosa V; Talarico R; Cantarini L; Matarese G
    J Leukoc Biol; 2016 May; 99(5):761-9. PubMed ID: 26598380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal tumor necrosis factor receptor I cell surface expression and NF-kappaB activation in tumor necrosis factor receptor-associated periodic syndrome.
    Nedjai B; Hitman GA; Yousaf N; Chernajovsky Y; Stjernberg-Salmela S; Pettersson T; Ranki A; Hawkins PN; Arkwright PD; McDermott MF; Turner MD
    Arthritis Rheum; 2008 Jan; 58(1):273-83. PubMed ID: 18163488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional analysis of a novel G87V TNFRSF1A mutation in patients with TNF receptor-associated periodic syndrome.
    Tsuji S; Matsuzaki H; Iseki M; Nagasu A; Hirano H; Ishihara K; Ueda N; Honda Y; Horiuchi T; Nishikomori R; Morita Y; Mukai T
    Clin Exp Immunol; 2019 Dec; 198(3):416-429. PubMed ID: 31429073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel TNFRSF1A splice mutation associated with increased nuclear factor kappaB (NF-kappaB) transcription factor activation in patients with tumour necrosis factor receptor associated periodic syndrome (TRAPS).
    Churchman SM; Church LD; Savic S; Coulthard LR; Hayward B; Nedjai B; Turner MD; Mathews RJ; Baguley E; Hitman GA; Gooi HC; Wood PM; Emery P; McDermott MF
    Ann Rheum Dis; 2008 Nov; 67(11):1589-95. PubMed ID: 18086728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The tumour necrosis factor receptor-associated periodic syndrome: current concepts.
    Stojanov S; McDermott MF
    Expert Rev Mol Med; 2005 Oct; 7(22):1-18. PubMed ID: 16216134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low TNF-induced NF-kappaB and p38 phosphorylation levels in leucocytes in tumour necrosis factor receptor-associated periodic syndrome.
    Stjernberg-Salmela S; Ranki A; Karenko L; Siitonen S; Mustonen H; Puolakkainen P; Sarna S; Pettersson T; Repo H
    Rheumatology (Oxford); 2010 Feb; 49(2):382-90. PubMed ID: 20071450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling of tumor necrosis factor receptor superfamily 1A mutants associated with tumor necrosis factor receptor-associated periodic syndrome indicates misfolding consistent with abnormal function.
    Rebelo SL; Bainbridge SE; Amel-Kashipaz MR; Radford PM; Powell RJ; Todd I; Tighe PJ
    Arthritis Rheum; 2006 Aug; 54(8):2674-87. PubMed ID: 16871532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TNFR1-d2 carrying the p.(Thr79Met) pathogenic variant is a potential novel actor of TNFα/TNFR1 signalling regulation in the pathophysiology of TRAPS.
    Rittore C; Méchin D; Sanchez E; Marinèche L; Ea V; Soler S; Vereecke M; Mallavialle A; Richard E; Duroux-Richard I; Apparailly F; Touitou I; Grandemange S
    Sci Rep; 2021 Feb; 11(1):4172. PubMed ID: 33603056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal disulfide-linked oligomerization results in ER retention and altered signaling by TNFR1 mutants in TNFR1-associated periodic fever syndrome (TRAPS).
    Lobito AA; Kimberley FC; Muppidi JR; Komarow H; Jackson AJ; Hull KM; Kastner DL; Screaton GR; Siegel RM
    Blood; 2006 Aug; 108(4):1320-7. PubMed ID: 16684962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of tumour necrosis factor (TNF)-α and TNFRSF1A R92Q mutation in the pathogenesis of TNF receptor-associated periodic syndrome and multiple sclerosis.
    Caminero A; Comabella M; Montalban X
    Clin Exp Immunol; 2011 Dec; 166(3):338-45. PubMed ID: 22059991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inositol-Requiring Enzyme 1-Mediated Downregulation of MicroRNA (miR)-146a and miR-155 in Primary Dermal Fibroblasts across Three
    Harrison SR; Scambler T; Oubussad L; Wong C; Wittmann M; McDermott MF; Savic S
    Front Immunol; 2018; 9():173. PubMed ID: 29467762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and functional characterisation of a novel TNFRSF1A c.605T>A/V173D cleavage site mutation associated with tumour necrosis factor receptor-associated periodic fever syndrome (TRAPS), cardiovascular complications and excellent response to etanercept treatment.
    Stojanov S; Dejaco C; Lohse P; Huss K; Duftner C; Belohradsky BH; Herold M; Schirmer M
    Ann Rheum Dis; 2008 Sep; 67(9):1292-8. PubMed ID: 18180277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TRAPS mutations in
    Akagi T; Hiramatsu-Asano S; Ikeda K; Hirano H; Tsuji S; Yahagi A; Iseki M; Matsuyama M; Mak TW; Nakano K; Ishihara K; Morita Y; Mukai T
    Front Immunol; 2022; 13():926175. PubMed ID: 35936010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutant forms of tumour necrosis factor receptor I that occur in TNF-receptor-associated periodic syndrome retain signalling functions but show abnormal behaviour.
    Todd I; Radford PM; Draper-Morgan KA; McIntosh R; Bainbridge S; Dickinson P; Jamhawi L; Sansaridis M; Huggins ML; Tighe PJ; Powell RJ
    Immunology; 2004 Sep; 113(1):65-79. PubMed ID: 15312137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.